68 results
PRE 14A
BVS
Bioventus Inc - Ordinary Shares
10 Apr 24
Preliminary proxy
4:08pm
ability to focus on creating long-term stockholder value.
However, as part of the Board’s regular evaluations of the Company’s corporate governance … to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs
8-K
EX-99.1
BVS
Bioventus Inc - Ordinary Shares
12 Mar 24
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
7:45am
number of products; our long-term growth depends on our ability to develop, acquire and commercialize new products, line extensions or expanded … and other assets
Long-term assets attributable to discontinued operations
Total assets
Liabilities and Stockholders’ Equity
Current liabilities
8-K
EX-10.1
oq1ung
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
8-K
EX-99.1
qlrp5
7 Nov 23
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
7:35am
8-K
EX-99.1
ute1tpp ldn7d8520hq9
8 Aug 23
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
8:02am
8-K
EX-99.1
zf8uvs3h6
26 May 23
Bioventus Completes Divestiture of its Wound Business
8:39am
8-K
EX-99.2
be4rm73
26 May 23
Bioventus Completes Divestiture of its Wound Business
8:39am
8-K
EX-99.1
o4htb4k046
16 May 23
Bioventus Reports First Quarter Financial Results
4:25pm
8-K
EX-99.1
7u1sp
16 May 23
Bioventus Announces Divestiture of its Wound Business
8:15am
8-K
EX-2.1
cx8akfnaywb7675s
16 May 23
Bioventus Announces Divestiture of its Wound Business
8:15am
8-K/A
EX-10.1
uj64h9et18fibmlmi sx
11 Apr 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-99.1
0fifqze289 q6l9
31 Mar 23
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
7:50am